Linked Life Data

11688727

Source:http://linkedlifedata.com/resource/pubmed/id/11688727

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2001-11-1
pubmed:abstractText
We report on the frequency, manifestations and reactions to gadolinium contrast media in patients who underwent MR imaging at our institution between 1988 and 1998. During a 10-year period 30,000 patients received an intravenous injection of 0.1 mmol/kg gadoterate meglumine or gadopentetate dimeglumine for an MRI examination. When a reaction occurred a written report was made (the events were categorized into mild, moderate, and severe). In the period of 10 years we obtained three reports of moderate or severe reactions to the administration of gadolinium. This paper discusses the safety issues of intravenous contrast media in MR imaging, focusing on two gadolinium complexes, gadoterate meglumine, gadopentetate dimeglumine.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0302-7430
pubmed:author
pubmed:issnType
Print
pubmed:volume
84
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
150-2
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed:year
2001
pubmed:articleTitle
Severe adverse reactions with contrast agents for magnetic resonance: clinical experience in 30,000 MR examinations.
pubmed:affiliation
Department of Radiology, AZ-VUB, Brussels, Belgium.
pubmed:publicationType
Journal Article, Case Reports